Integra LifeSciences (IART) Tops Q4 EPS by 1c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
February 25, 2016 4:01 PM ESTFourth Quarter Revenues Increased 10.1% to $241.2 Million Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39 Full Year Organic Revenues Increased 6.7%
PLAINSBORO, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) --  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the fourth quarter and full year ending December 31, 2015.Â
Highlights:Â
Fourth quarter revenue increased 10.1% over the prior year quarter to $241.2 million;Organic revenues increased 3.9% in the fourth quarter... More